Skip to main content
Erschienen in: Diabetologia 3/2015

01.03.2015 | Article

Autophagy in the posterior interosseous nerve of patients with type 1 and type 2 diabetes mellitus: an ultrastructural study

verfasst von: Ayman A. M. Osman, Lars B. Dahlin, Niels O. B. Thomsen, Simin Mohseni

Erschienen in: Diabetologia | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We addressed the question of whether the autophagy pathway occurs in human peripheral nerves and whether this pathway is associated with peripheral neuropathy in diabetes mellitus.

Methods

By using electron microscopy, we evaluated the presence of autophagy-related structures and neuropathy in the posterior interosseous nerve of patients who had undergone carpal tunnel release and had type 1 or type 2 diabetes mellitus, and in patients with no diabetes (controls).

Results

Autophagy-related ultrastructures were observed in the samples taken from all patients of the three groups. The number of autophagy-associated structures was significantly higher (p < 0.05) in the nerves of patients with type 1 than type 2 diabetes. Qualitative and quantitative evaluations of fascicle area, diameter of myelinated and unmyelinated nerve fibres, the density of myelinated and unmyelinated fibres and the g-ratio of myelinated fibres were performed. We found degeneration and regeneration of a few myelinated axons in controls, and a well-developed neuropathy with the loss of large myelinated axons and the presence of many small ones in patients with diabetes. The pathology in type 1 diabetes was more extensive than in type 2 diabetes.

Conclusions/interpretation

The results of this study show that the human peripheral nerves have access to the autophagy machinery, and this pathway may be regulated differently in type 1 and type 2 diabetes; insulin, presence of extensive neuropathy, and/or other factors such as duration of diabetes and HbA1c level may underlie this differential regulation.
Literatur
1.
Zurück zum Zitat Dyck P, Kratz K, Karnes J et al (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43:817–824PubMedCrossRef Dyck P, Kratz K, Karnes J et al (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43:817–824PubMedCrossRef
3.
Zurück zum Zitat Low PA, Nickander KK, Tritschler HJ (1997) The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46(Suppl 2):S38–S42PubMedCrossRef Low PA, Nickander KK, Tritschler HJ (1997) The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46(Suppl 2):S38–S42PubMedCrossRef
4.
Zurück zum Zitat Sheetz MJ, King GL (2002) Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 288:2579–2588PubMedCrossRef Sheetz MJ, King GL (2002) Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA 288:2579–2588PubMedCrossRef
5.
Zurück zum Zitat Jamali R, Mohseni S (2005) Hypoglycaemia causes degeneration of large myelinated nerve fibres in the vagus nerve of insulin-treated diabetic BB/Wor rats. Acta Neuropathol 109:198–206PubMedCrossRef Jamali R, Mohseni S (2005) Hypoglycaemia causes degeneration of large myelinated nerve fibres in the vagus nerve of insulin-treated diabetic BB/Wor rats. Acta Neuropathol 109:198–206PubMedCrossRef
6.
Zurück zum Zitat Jamali R, Mohseni S (2006) Differential neuropathies in hyperglycemic and hypoglycemic diabetic rats. J Neuropathol Exp Neurol 65:1118–1125PubMedCrossRef Jamali R, Mohseni S (2006) Differential neuropathies in hyperglycemic and hypoglycemic diabetic rats. J Neuropathol Exp Neurol 65:1118–1125PubMedCrossRef
7.
Zurück zum Zitat Mohseni S (2001) Hypoglycemic neuropathy. Acta Neuropathol 102:413–421PubMed Mohseni S (2001) Hypoglycemic neuropathy. Acta Neuropathol 102:413–421PubMed
8.
Zurück zum Zitat Mohseni S (2011) Autophagy in insulin-induced hypoglycaemic neuropathy. Pathology 43:254–260PubMedCrossRef Mohseni S (2011) Autophagy in insulin-induced hypoglycaemic neuropathy. Pathology 43:254–260PubMedCrossRef
9.
Zurück zum Zitat Mohseni S, Hildebrand C (1998) Hypoglycaemic neuropathy in BB/Wor rats treated with insulin implants: electron microscopic observations. Acta Neuropathol 96:151–156PubMedCrossRef Mohseni S, Hildebrand C (1998) Hypoglycaemic neuropathy in BB/Wor rats treated with insulin implants: electron microscopic observations. Acta Neuropathol 96:151–156PubMedCrossRef
10.
Zurück zum Zitat Mohseni S, Hildebrand C (1998) Neuropathy in diabetic BB/Wor rats treated with insulin implants. Acta Neuropathol 96:144–150PubMedCrossRef Mohseni S, Hildebrand C (1998) Neuropathy in diabetic BB/Wor rats treated with insulin implants. Acta Neuropathol 96:144–150PubMedCrossRef
11.
Zurück zum Zitat Mohseni S, Lillesaar C, Hildebrand C, Theodorsson E (2000) Hypoglycaemic neuropathy: occurrence of axon terminals in plantar skin and plantar muscle of diabetic BB/Wor rats treated with insulin implants. Acta Neuropathol 99:257–262PubMedCrossRef Mohseni S, Lillesaar C, Hildebrand C, Theodorsson E (2000) Hypoglycaemic neuropathy: occurrence of axon terminals in plantar skin and plantar muscle of diabetic BB/Wor rats treated with insulin implants. Acta Neuropathol 99:257–262PubMedCrossRef
12.
Zurück zum Zitat Klionsky DJ, Abdalla FC, Abeliovich H et al (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8:445–544PubMedCentralPubMedCrossRef Klionsky DJ, Abdalla FC, Abeliovich H et al (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8:445–544PubMedCentralPubMedCrossRef
15.
16.
Zurück zum Zitat Piao Z, Wang W, Xu X et al (2004) Autophagy of neuron axon during regeneration of rat sciatic nerves. J First Mil Med Uni 2:361–364 Piao Z, Wang W, Xu X et al (2004) Autophagy of neuron axon during regeneration of rat sciatic nerves. J First Mil Med Uni 2:361–364
17.
18.
Zurück zum Zitat Kosacka J, Nowicki M, Blüher M et al (2013) Increased autophagy in peripheral nerves may protect Wistar Ottawa Karlsburg W rats against neuropathy. Exp Neurol 250:125–135PubMedCrossRef Kosacka J, Nowicki M, Blüher M et al (2013) Increased autophagy in peripheral nerves may protect Wistar Ottawa Karlsburg W rats against neuropathy. Exp Neurol 250:125–135PubMedCrossRef
19.
Zurück zum Zitat Towns R, Kabeya Y, Yoshimori T et al (2005) Sera from patients with type 2 diabetes and neuropathy induce autophagy and colocalization with mitochondria in SY5Y cells. Autophagy 1:163–170PubMedCrossRef Towns R, Kabeya Y, Yoshimori T et al (2005) Sera from patients with type 2 diabetes and neuropathy induce autophagy and colocalization with mitochondria in SY5Y cells. Autophagy 1:163–170PubMedCrossRef
20.
Zurück zum Zitat Marinelli S, Nazio F, Tinari A et al (2014) Schwann cell autophagy counteracts the onset and chronification of neuropathic pain. Pain 155:93–107PubMedCrossRef Marinelli S, Nazio F, Tinari A et al (2014) Schwann cell autophagy counteracts the onset and chronification of neuropathic pain. Pain 155:93–107PubMedCrossRef
21.
Zurück zum Zitat Thomsen NOB, Mojaddidi M, Malik RA, Dahlin LB (2009) Reduced myelinated nerve fibre and endoneurial capillary densities in the forearm of diabetic and non-diabetic patients with carpal tunnel syndrome. Acta Neuropathol 118:785–791PubMedCrossRef Thomsen NOB, Mojaddidi M, Malik RA, Dahlin LB (2009) Reduced myelinated nerve fibre and endoneurial capillary densities in the forearm of diabetic and non-diabetic patients with carpal tunnel syndrome. Acta Neuropathol 118:785–791PubMedCrossRef
22.
Zurück zum Zitat Thomsen NOB, Mojaddidi M, Malik RA, Dahlin LB (2009) Biopsy of the posterior interosseous nerve: a low morbidity method for assessment of peripheral nerve disorders. Diabet Med 26:100–104PubMedCrossRef Thomsen NOB, Mojaddidi M, Malik RA, Dahlin LB (2009) Biopsy of the posterior interosseous nerve: a low morbidity method for assessment of peripheral nerve disorders. Diabet Med 26:100–104PubMedCrossRef
23.
Zurück zum Zitat Thomsen NO, Cederlund R, Rosen I, Björk J, Dahlin LB (2009) Clinical outcomes of surgical release among diabetic patients with carpal tunnel syndrome: prospective follow-up with matched controls. J Hand Surg [Am] 34:1177–1187CrossRef Thomsen NO, Cederlund R, Rosen I, Björk J, Dahlin LB (2009) Clinical outcomes of surgical release among diabetic patients with carpal tunnel syndrome: prospective follow-up with matched controls. J Hand Surg [Am] 34:1177–1187CrossRef
24.
Zurück zum Zitat Mojaddidi M, Ahmed M, Ali R et al (2014) Molecular and pathological studies in the posterior interosseous nerve of diabetic and non-diabetic patients with carpal tunnel syndrome. Diabetologia 57:1711–1719PubMedCrossRef Mojaddidi M, Ahmed M, Ali R et al (2014) Molecular and pathological studies in the posterior interosseous nerve of diabetic and non-diabetic patients with carpal tunnel syndrome. Diabetologia 57:1711–1719PubMedCrossRef
25.
Zurück zum Zitat England JD, Gronseth GS, Franklin G et al (2005) Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 64:199–207PubMedCrossRef England JD, Gronseth GS, Franklin G et al (2005) Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation. Neurology 64:199–207PubMedCrossRef
26.
Zurück zum Zitat Backues SK, Chen D, Ruan J, Xie Z, Klionsky DJ (2014) Estimating the size and number of autophagic bodies by electron microscopy. Autophagy 10:155–164PubMedCrossRef Backues SK, Chen D, Ruan J, Xie Z, Klionsky DJ (2014) Estimating the size and number of autophagic bodies by electron microscopy. Autophagy 10:155–164PubMedCrossRef
27.
Zurück zum Zitat Yamamoto A, Cremona ML, Rothman JE (2006) Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J Cell Biol 172:719–731PubMedCentralPubMedCrossRef Yamamoto A, Cremona ML, Rothman JE (2006) Autophagy-mediated clearance of huntingtin aggregates triggered by the insulin-signaling pathway. J Cell Biol 172:719–731PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Lv P, Huang J, Yang J et al (2014) Autophagy in muscle of glucose-infusion hyperglycemia rats and streptozotocin-induced hyperglycemia rats via selective activation of m-TOR or FoxO3. PLoS One 9:e87254PubMedCentralPubMedCrossRef Lv P, Huang J, Yang J et al (2014) Autophagy in muscle of glucose-infusion hyperglycemia rats and streptozotocin-induced hyperglycemia rats via selective activation of m-TOR or FoxO3. PLoS One 9:e87254PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Callaghan B, Feldman E (2013) The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann Neurol 74:397–403PubMed Callaghan B, Feldman E (2013) The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann Neurol 74:397–403PubMed
31.
Zurück zum Zitat Nixon RA (2006) Autophagy in neurodegenerative disease: friend, foe or turncoat? Trends Neurosci 29:528–535PubMedCrossRef Nixon RA (2006) Autophagy in neurodegenerative disease: friend, foe or turncoat? Trends Neurosci 29:528–535PubMedCrossRef
32.
Zurück zum Zitat Yue Z, Friedman L, Komatsu M, Tanaka K (2009) The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases. Biochim Biophys Acta 1793:1496–1507PubMedCentralPubMedCrossRef Yue Z, Friedman L, Komatsu M, Tanaka K (2009) The cellular pathways of neuronal autophagy and their implication in neurodegenerative diseases. Biochim Biophys Acta 1793:1496–1507PubMedCentralPubMedCrossRef
33.
34.
Zurück zum Zitat Malik RA, Veves A, Walker D et al (2001) Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol 47:367–374 Malik RA, Veves A, Walker D et al (2001) Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol 47:367–374
Metadaten
Titel
Autophagy in the posterior interosseous nerve of patients with type 1 and type 2 diabetes mellitus: an ultrastructural study
verfasst von
Ayman A. M. Osman
Lars B. Dahlin
Niels O. B. Thomsen
Simin Mohseni
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Diabetologia / Ausgabe 3/2015
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-014-3477-4

Weitere Artikel der Ausgabe 3/2015

Diabetologia 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.